NPPB and atrial fibrillation: The risks (OR) for an increased NT-proBNP ≥ 2910 pg/mL are: 3.7-fold (p = 0.003) for patients aged >73 years, 3.7-fold (p = 0.007) for a medical history of atrial fibrillation, 4.9-fold (p = 0.002) for eGFR ≤80 mL/min/1.73 m2, 5.9-fold (p = 0.001) for TAPSE ≤ 22 mm, and 5.2-fold (p = 0.002) for LAVi ≥ 54 mL/m2, compared with values below the predictors’ thresholds (Figure 5, Table S3).